Skip to main content

Idiopathic Pulmonary Fibrosis Prespective Outcomes (IPF-PRO) Registry

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Pulmonary, Allergy, and Critical Care Medicine

Awarded By

Boehringer Ingelheim Pharmaceuticals, Inc.

Start Date

May 1, 2014

End Date

November 30, 2024
 

Administered By

Medicine, Pulmonary, Allergy, and Critical Care Medicine

Awarded By

Boehringer Ingelheim Pharmaceuticals, Inc.

Start Date

May 1, 2014

End Date

November 30, 2024